Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Pharming Group NV
PHARMCurrent price
0.74 EUR
+0.019 EUR (+2.72%)
Last closed
8.1 USD
Company
www.pharming.com
ISIN
US71716E1055
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Amsterdam
Capitalization
554 215 232 USD
Yield for 12 month
-31.12 %
1Y
3Y
5Y
10Y
15Y
PHARM
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands. Address: Darwinweg 24, Leiden, Netherlands, 2333 CR
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+245 316 000 USD
Last Year
+205 622 000 USD
Current Quarter
+75 062 600 USD
Last Quarter
+74 030 646 USD
Current Year
+220 104 000 USD
Last Year
+188 060 000 USD
Current Quarter
+68 224 141 USD
Last Quarter
+66 038 134 USD
Key Figures PHARM
1 year
3 years
5 years
10 years
EBITDA
-3 057 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-1.38 %
PEG Ratio
–
Return On Equity TTM
-8.18 %
Wall Street Target Price
–
Revenue TTM
285 744 992 USD
Book Value
0.44 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
12.2 %
Dividend Yield
–
Gross Profit TTM
188 060 000 USD
Earnings per share
-0.27 USD
Diluted Eps TTM
-0.27 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-61.5 %
Profit Margin
-6.24 %
Dividend Analytics PHARM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PHARM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation PHARM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
169.4915
Enterprise Value Revenue
1.7348
Price Sales TTM
1.9395
Enterprise Value EBITDA
65.6059
Price Book MRQ
2.4545
Financials PHARM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PHARM
For 52 weeks
6.65 USD
13.2 USD
50 Day MA
8.17 USD
Shares Short Prior Month
4 100
200 Day MA
9.3 USD
Short Ratio
1.17
Shares Short
9 065
Short Percent
0.01 %
BeatStart